Table 2.
Characteristic | Caucasian n = 3,742 |
African-American n = 2,779 |
Total n = 6,521 |
---|---|---|---|
In-hospital death (%)** | 10.3 | 12.9 | 11.4 |
1-year mortality (%)* | 22.5 | 25.3 | 23.7 |
Length of stay (in days):*** | 3.0 | 4.0 | 4.0 |
median (interquartile range) | (2.0 to 6.0) | (2.0 to 7.0) | (2.0 to 7.0) |
Diagnosis-related group classification:*** | |||
Medical (%) | 66.8 | 71.9 | 69.0 |
Surgical (%) | 33.2 | 28.1 | 31.0 |
Teaching hospital (%)*** | 40.3 | 46.8 | 43.1 |
Admission classified as emergent (%)*** | 43.5 | 52.4 | 47.3 |
Transferred from another hospital (%) | 4.3 | 5.2 | 4.7 |
Comorbidity index score: mean (std. dev.) *** | 1.85 (2.83) | 2.18 (2.70) | 1.99 (2.78) |
Heart failure (%) | 11.0 | 9.6 | |
Cerebrovascular disease (%) | 5.9 | 6.3 | |
Diabetes mellitus (%) ** | 10.7 | 13.4 | |
Myocardial infaction (%) *** | 6.6 | 4.0 | |
Perivascular disease (%) | 3.3 | 2.6 | |
Renal failure (%) *** | 4.5 | 14.2 | |
AIDS (%) * | 0 | 0.3 | |
Metastatic cancer (%) | 2.0 | 1.5 | |
Any malignancy (%) ** | 4.8 | 3.0 | |
Severe liver disease (%) | 2.2 | 1.8 | |
Pericarditis (%) *** | 0.6 | 1.9 | |
Pleuritis (%) | 2.7 | 3.4 | |
Nephritis (%) *** | 6.2 | 15.5 | |
Thrombocytopenia (%) *** | 4.0 | 6.1 |
p < 0.05 comparing Caucasians to African-Americans by t-tests, chi-square tests, or Wilcoxon rank sum tests, as appropriate.
p < 0.001 comparing Caucasians to African-Americans by t-tests, chi-square tests, or Wilcoxon rank sum tests, as appropriate.
p < 0.0001 comparing Caucasians to African-Americans by t-tests, chi-square tests, or Wilcoxon rank sum tests, as appropriate.